ROCHE DIABETES CARE GMBH
- Shared products
- Lancet, Lancets, SELF-TEST FOR GLUCOSE, Self-test instrument for glucose, Software
- Shared products
- Lancet, Lancets, SELF-TEST FOR GLUCOSE, Self-test instrument for glucose, Software
- Shared products
- Lancet, Lancets, SELF-TEST FOR GLUCOSE, SELF-TEST FOR GLUCOSE MONITORING IN INTERSTITIAL FLUID (PERCUTANEOUS) - SENSOR/TRANSMITTER, Self-test instrument for glucose
- Shared products
- GLUCOSE - POINT OF CARE TESTING (PROFESSIONAL), SELF-TEST FOR GLUCOSE, SELF-TEST FOR GLUCOSE MONITORING IN INTERSTITIAL FLUID (PERCUTANEOUS) - SENSOR/TRANSMITTER, Self-test instrument for glucose, Software
- Shared products
- COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS III, Lancet, Lancets, SELF-TEST FOR GLUCOSE, Self-test instrument for glucose
Explore comprehensive manufacturer profile for ROCHE DIABETES CARE GMBH based in Germany through Pure Global AI's free Brazil medical device database. This manufacturer has 38 products registered with ANVISA across 16 unique technical categories. Their regulatory history spans from Jan 10, 2011 to Jul 07, 2025.
This page provides detailed insights including 5 recent product registrations including SELF-TEST FOR GLUCOSE MONITORING IN INTERSTITIAL FLUID (PERCUTANEOUS) - SENSOR/TRANSMITTER, 5 most popular products with SELF-TEST FOR GLUCOSE having 10 registrations, 2 registration holders including ROCHE DIABETES CARE BRASIL LTDA, and 5 key competitors with OK BIOTECH CO., LTD. sharing 5 products. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, enabling global MedTech companies to analyze market dynamics and identify opportunities.